Akcije

Archive of Oncology
kako citirati ovaj članak
podeli ovaj članak
Direktan link

Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:3
  • preuzimanja u poslednjih 30 dana:3

Sadržaj

članak: 4 od 4  
Back povratak na rezultate
Archive of Oncology
2019, vol. 25, br. 2, str. 25-27
Long-term survival of a patient with locally advanced hilar cholangiocarcinoma (Klatskin tumor): A case report and review on high level evidence
(naslov ne postoji na srpskom)
Vahedian Jalala, Reza Babaei Mohammadb, Zare Mehrjardi Alic, Almasi Alia, Amir Yasin Ahmadi Seyyedd, Hadizadeh Omida
aIran University of Medical Sciences, Firoozgar Clinical Research Development Center (FCRDC), Department of Surgery, Tehran, Iran
bIran University of Medical Sciences, Firoozgar Clinical Research Development Center (FCRDC), Department of Interventional Radiology, Tehran, Iran
cIran University of Medical Sciences, Firoozgar Clinical Research Development Center (FCRDC), Department of Pathology, Tehran, Iran
dIran University of Medical Sciences, Student Research Committee, Tehran, Iran

e-adresa: omid_hadi_zadeh@yahoo.com
Ključne reči: Cholangiocarcinoma; Survival; Stents
Sažetak
(ne postoji na srpskom)
Cholangiocarcinoma, malignant tumor of epithelial cells of bile ducts has poor overall survival and prognosis. We report a case of non-resectable cholangiocarcinoma with a 57-month survival after incomplete R2 surgical margin resection of the tumor. A 52-year old man with generalized itching, jaundice, brownish urine, mild abdominal pain and weight loss of 8 kg in last two months presented. Imaging and surgical workups showed hilar cholangiocarcinoma (Klatskin tumor). Along with incomplete R2 margin resection we performed stent embedding and post-operative adjuvant chemotherapy. Based on current literature data there is no superiority of adjuvant chemotherapy after complete R0 resection compared to incomplete R2 resection. However, it seems that partial resection along with stent embedding and applied adjuvant chemotherapy in cases of locally advanced non-resectable cholangiocarcinoma may increase survival rate.
Reference

Bird, N.T.E., McKenna, A., Dodd, J., Poston, G., Jones, R., Malik, H. (2018) Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma. British Journal of Surgery, 105(11): 1408-1416

Blechacz, B., Gores, G.J. (2008) Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment. Hepatology, 48(1): 308-321

Carriaga, M.T., Henson, D.E. (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer, 75(S1): 171-190

Deoliveira, M.L., Cunningham, S.C., Cameron, J.L., Kamangar, F., Winter, J.M., Lillemoe, K.D., Schulick, R.D. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Annals of Surgery, 245(5): 755-762

Hirschfield, G.M., Karlsen, T.H., Lindor, K.D., Adams, D.H. (2013) Primary sclerosing cholangitis. Lancet, 382(9904): 60096-60099

Jarnagin, W.R., Fong, Y., Dematteo, R.P., Gonen, M., Burke, E.C., Bodniewicz, J., Blumgart, L.H. (2001) Staging, Resectability, and Outcome in 225 Patients with Hilar Cholangiocarcinoma. Annals of Surgery, 234(4):507-519

Kahaleh, M., Mishra, R., Shami, V.M., Northup, P.G., Berg, C.L., Bashlor, P., Yeaton, P. (2008) Unresectable Cholangiocarcinoma: Comparison of Survival in Biliary Stenting Alone Versus Stenting with Photodynamic Therapy. Clinical Gastroenterology and Hepatology, 6(3):290-297

Khan, S.A., Taylor-Robinson, S.D., Toledano, M.B., Beck, A., Elliott, P., Thomas, H.C. (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. Journal of Hepatology, 37(6): 297-297

Khan, S.A., Thomas, H.C., Davidson, B.R., Taylor-Robinson, S.D. (2005) Cholangiocarcinoma. Lancet, 366(9493): 1303-1314

Li, M., Bi, X., Li, Z., Huang, Z., Han, Y., Zhao, J., Zhao, H., Cai, J. (2016) Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Journal of Surgical Research, 203(1): 163-173

Mavros, M.N., Economopoulos, K.P., Alexiou, V.G., Pawlik, T.M. (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: Systematic review and meta-analysis. JAMA Surgery, 149(6): 565-565

Mihalache, F., Tantau, M., Diaconu, B., Acalovschi, M. (2010) Survival and quality of life of cholangiocarcinoma patients: A prospective study over a 4 year period. Journal of Gastrointestinal & Liver Diseases, (3): 19-19

Murakami, Y., Uemura, K., Sudo, T., Hayashidani, Y., Hashimoto, Y., Nakamura, H., Nakashima, A., Sueda, T. (2009) Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery, 13(8): 1470-1479

Nathan, H., Pawlik, T.M., Wolfgang, C.L., Choti, M.A., Cameron, J.L., Schulick, R.D. (2007) Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database Analysis. Journal of Gastrointestinal Surgery, 11(11): 1488-1497

Olnes, M.J., Erlich, R. (2004) A Review and Update on Cholangiocarcinoma. Oncology, 66(3): 167-179

Palmer, W.C., Patel, T. (2012) Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. Journal of Hepatology, 57(1): 69-76

4

Parker, S.L., Tong, T., Bolden, S., Wingo, P.A. (1997) Cancer statistics, 1997. CA: A cancer journal for clinicians, 47(1): 5-27

Ren, H., Yu, T., Liu, C., Li, Y. (2011) Diabetes mellitus and increased risk of biliary tract cancer: Systematic review and meta-analysis. Cancer Causes & Control, 22(6): 837-847

Shaib, Y., El-Serag, H. (2004) The Epidemiology of Cholangiocarcinoma. Seminars in Liver Disease, 24(02):115-125

Tang, H., Lu, W., Li, B., Meng, X., Dong, J. (2016) Influence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: A meta-analysis. Medicine, 95(35): e4621-e4621

Tsao, J.I., Nimura, Y., Kamiya, J., Hayakawa, N., Kondo, S., Nagino, M., Dugan, J.M. (2000) Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Annals of Surgery, 232(2):166-174

Tyson, G.L., El-Serag, H.B. (2011) Risk factors for cholangiocarcinoma. Hepatology, 54(1): 173-184

Wellner, U.F., Shen, Y., Keck, T., Jin, W., Xu, Z.W. (2017) The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: A meta-analysis for the 5-year survival. Surgery Today, 47(3): 271-279

Zhou, Y., Liu, S., Wu, L., Wan, T. (2017) Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian Journal of Surgery, 40(2): 129-138
   

O članku

jezik rada: engleski
vrsta rada: prikaz slučaja
DOI: 10.2298/AOO190220004V
objavljen u SCIndeksu: 29.07.2019.
metod recenzije: jednostruko anoniman
Creative Commons License 4.0

Povezani članci

Nema povezanih članaka